Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William.

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.
Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease.
Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease 
Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F
Prevalence and Lifetime Risk of Endoscopy-related Complications Among Patients With Inflammatory Bowel Disease  Jason Ferreira, Mona Akbari, Laurie Gashin,
The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Millie D. Long, Bruce E. Sands 
Pichamol Jirapinyo, Christopher C. Thompson 
Treatment of Esophageal (Noncardiac) Chest Pain: An Expert Review
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010  Tine Jess, Morten Frisch, Jacob Simonsen 
Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review  Marin J. de Jong,
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease
Evidence for Life Before Inflammatory Bowel Disease
Evaluation and Treatment of Obesity
Short-Bowel Syndrome Clinical Gastroenterology and Hepatology
Does Karnofsky Performance Status of Patients With Cirrhosis on the Transplant Waitlist Meet the Eyeball Test?  Elliot B. Tapper, MD  Clinical Gastroenterology.
Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis  Zobair M. Younossi  Clinical.
A Patient Has a 3-Centimeter Cecal Polyp on Chronic Anticoagulation for a Mechanical Mitral Valve Prosthesis  Andrew J. Overhiser, Douglas K. Rex  Clinical.
Genetics of Colonic Polyposis
Clinical Features, Treatment, and Survival of Patients With Colorectal Cancer With or Without Inflammatory Bowel Disease  Raja Affendi Raja Ali, Cara.
Translating Improved Quality of Care Into an Improved Quality of Life for Patients With Inflammatory Bowel Disease  Corey A. Siegel, John I. Allen, Gil.
May Min, Jason Ferreira, Charles Wang 
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
David J. Hass, Colleen M. Brensinger, James D. Lewis, Gary R
Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Severe Constipation Clinical Gastroenterology and Hepatology
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
William D. Leslie  Clinical Gastroenterology and Hepatology 
New Models of Gastroenterology Practice
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis  Erin W. Thackeray, Phunchai Charatcharoenwitthaya,
David H. Bruining, William J. Sandborn 
Prevalence and Lifetime Risk of Endoscopy-related Complications Among Patients With Inflammatory Bowel Disease  Jason Ferreira, Mona Akbari, Laurie Gashin,
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease  Aoibhlinn O'Toole, Alaa Alakkari, Denise Keegan, Glen Doherty, Hugh.
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation  Michael.
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Javier Oliver, Blanca Rueda, Miguel A
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication  Lauren A. Beste, George.
Severe irritable bowel and functional abdominal pain syndromes: Managing the patient and health care costs  George F. Longstreth, Douglas A. Drossman 
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Resolution of Decompensated Cirrhosis From Wilson’s Disease With Zinc Monotherapy: A Potential Therapeutic Option?  Vanessa D. Lee, Patrick G. Northup,
Patrick Yachimski, William P. Puricelli, Norman S. Nishioka 
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Issue Highlights Clinical Gastroenterology and Hepatology
Medical Therapy for Refractory Pediatric Crohn’s Disease
Issue Highlights Clinical Gastroenterology and Hepatology
Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F
Coping Strategies and Interpersonal Support in Patients With Irritable Bowel Syndrome and Inflammatory Bowel Disease  Michael P. Jones, Sarah Wessinger,
The Role of Psychosocial Care in Adapting to Health Care Reform
Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N
Presentation transcript:

Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William Disanti, Ramona O. Rajapakse, Burton I. Korelitz, Georgia Panagopoulos, Jason Bratcher  Clinical Gastroenterology and Hepatology  Volume 4, Issue 8, Pages 1025-1029 (August 2006) DOI: 10.1016/j.cgh.2006.03.018 Copyright © 2006 American Gastroenterological Association Terms and Conditions

Figure 1 Rate of neoplasms after 6-MP for IBD in sustained leukopenic vs control groups. Clinical Gastroenterology and Hepatology 2006 4, 1025-1029DOI: (10.1016/j.cgh.2006.03.018) Copyright © 2006 American Gastroenterological Association Terms and Conditions